A

Alpine Immune Sciences Inc
F:34LA

Watchlist Manager
Alpine Immune Sciences Inc
F:34LA
Watchlist
Price: 59 EUR Market Closed
Market Cap: 4B EUR

Wall Street
Price Targets

34LA Price Targets Summary
Alpine Immune Sciences Inc

There are no price targets for 34LA.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Alpine Immune Sciences Inc Competitors:
Price Targets
7774
Japan Tissue Engineering Co Ltd
97% Upside
688235
Beigene Ltd
36% Upside
ANAB
AnaptysBio Inc
14% Upside
LGND
Ligand Pharmaceuticals Inc
28% Upside
GLPG
Galapagos NV
10% Upside
VRTX
Vertex Pharmaceuticals Inc
10% Upside
6855
Ascentage Pharma Group International
97% Upside
300142
Walvax Biotechnology Co Ltd
36% Downside

Revenue
Forecast

Revenue Estimate
Alpine Immune Sciences Inc

For the last 8 years the compound annual growth rate for Alpine Immune Sciences Inc's revenue is 82%. The projected CAGR for the next 1 year is -15%.

82%
Past Growth
-15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Alpine Immune Sciences Inc

Operating Income forecast
is not available for
Alpine Immune Sciences Inc

Net Income
Forecast

Net Income Estimate
Alpine Immune Sciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 34LA's stock price target?
Not Available

34LA doesn't have any price targets made by Wall Street professionals.

What is Alpine Immune Sciences Inc's Revenue forecast?
Projected CAGR
-15%

For the last 8 years the compound annual growth rate for Alpine Immune Sciences Inc's revenue is 82%. The projected CAGR for the next 1 year is -15%.

Back to Top